Recidiva locorregional diferida de mesotelioma pleural

García-Gómez, Francisco Javier; García-Manrique, Teresa; Castro-Montaño, Juan.
Arch. bronconeumol. (Ed. impr.) ; 53(10): 584-585, oct. 2017. ilus
Artículo en Español | IBECS (España) | ID: ibc-167427

Documentos relacionados

  1. Predicting survival for patients with mesothelioma: development of the PLACE prognostic model.
  2. Carbon Dioxide Blower Facilitates Visceral Pleurectomy in Malignant Pleural Mesothelioma.
  3. Whole-genome sequencing of human malignant mesothelioma tumours and cell lines.
  4. Wnt/IL-1ß/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
  5. Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma.
  6. Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs <i>in vitro</i> models of mesothelioma.
  7. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?
  8. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
  9. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
  10. ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma.